ATE163980T1 - Antivirale topische pharmazeutische zusammensetzungen - Google Patents

Antivirale topische pharmazeutische zusammensetzungen

Info

Publication number
ATE163980T1
ATE163980T1 AT94902967T AT94902967T ATE163980T1 AT E163980 T1 ATE163980 T1 AT E163980T1 AT 94902967 T AT94902967 T AT 94902967T AT 94902967 T AT94902967 T AT 94902967T AT E163980 T1 ATE163980 T1 AT E163980T1
Authority
AT
Austria
Prior art keywords
topical pharmaceutical
pharmaceutical compositions
antiviral
antiviral topical
dispersed
Prior art date
Application number
AT94902967T
Other languages
English (en)
Inventor
Amnon Sintov
Rina Uzan
Original Assignee
Agis Ind 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Ind 1983 Ltd filed Critical Agis Ind 1983 Ltd
Application granted granted Critical
Publication of ATE163980T1 publication Critical patent/ATE163980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94902967T 1992-12-30 1993-12-29 Antivirale topische pharmazeutische zusammensetzungen ATE163980T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10428392A IL104283A (en) 1992-12-30 1992-12-30 Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Publications (1)

Publication Number Publication Date
ATE163980T1 true ATE163980T1 (de) 1998-03-15

Family

ID=11064372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902967T ATE163980T1 (de) 1992-12-30 1993-12-29 Antivirale topische pharmazeutische zusammensetzungen

Country Status (9)

Country Link
US (1) US5585379A (de)
EP (1) EP0677126B1 (de)
JP (1) JPH08505850A (de)
AT (1) ATE163980T1 (de)
AU (1) AU671704B2 (de)
CA (1) CA2152907C (de)
DE (1) DE69317444T2 (de)
IL (1) IL104283A (de)
WO (1) WO1994015614A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666842B1 (de) * 1992-10-30 1998-06-24 G.D. Searle & Co. Hydroxyethylaminosulfamidsäure-derivate verwendbar als inhibitoren retroviraler proteasen
IL110380A0 (en) * 1994-07-20 1994-10-21 Agis Ind 1983 Ltd Antiviral topical pharmaceutical compositions
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
JPH10508856A (ja) * 1994-11-15 1998-09-02 オスモティクス コーポレーション スキンケア組成物及びその適用方法
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
EP0787490A1 (de) * 1996-01-31 1997-08-06 Agis Industries (1983) Ltd Topische Zusammensetzung zur Prevention und Behandlung der mit Herpesvirus assoziierten Verletzungen und Wunde
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6596763B1 (en) 1996-11-14 2003-07-22 Lipomedica Ehf. Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6107303A (en) * 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
BRPI0015567B8 (pt) * 1999-11-05 2021-05-25 Emisphere Tech Inc composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
RU2300516C2 (ru) * 1999-11-05 2007-06-10 Эмисфере Текнолоджиз, Инк. Соединения феноксикарбоновой кислоты и композиции для доставки активных веществ
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
EP1741425B1 (de) * 2004-04-05 2008-05-28 Laboratorios Liomont, S.A. de C.V. Neue antivirale pharmazeutische zusammensetzung
MXPA06013295A (es) * 2004-05-19 2007-02-22 Emisphere Tech Inc Formulaciones de aciclovir.
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
ITMI20071724A1 (it) * 2007-09-05 2009-03-06 Fidia Farmaceutici Formulazioni topiche antivirali in forma di gel bioadesivo
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
EP2782585B1 (de) 2011-11-23 2018-12-26 3B Pharmaceuticals, Inc. Antivirale formulierungen
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10231924B2 (en) 2016-03-23 2019-03-19 Cmpd Licensing, Llc Compounded topical composition and method
CN111821254B (zh) * 2019-04-18 2021-10-15 华东师范大学 一种抗病毒水凝胶及其制备方法和应用
AU2020292356A1 (en) * 2019-06-14 2022-01-20 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof
CN114010590B (zh) * 2021-11-24 2023-12-01 华东师范大学 一种核苷类抗病毒药物凝胶及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物

Also Published As

Publication number Publication date
DE69317444D1 (de) 1998-04-16
JPH08505850A (ja) 1996-06-25
AU5711894A (en) 1994-08-15
DE69317444T2 (de) 1998-08-27
WO1994015614A1 (en) 1994-07-21
IL104283A0 (en) 1993-05-13
CA2152907A1 (en) 1994-07-21
IL104283A (en) 1996-12-05
EP0677126A1 (de) 1995-10-18
EP0677126B1 (de) 1998-03-11
US5585379A (en) 1996-12-17
AU671704B2 (en) 1996-09-05
CA2152907C (en) 2004-03-30

Similar Documents

Publication Publication Date Title
DE69317444D1 (de) Antivirale topische pharmazeutische zusammensetzungen
SE9301489D0 (sv) Veterinary composition
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
NO992638L (no) Gelformulering for topisk legemiddellevering
CA2076465A1 (en) Cell binding agent conjugates of analogues and derivatives of cc-1065
TR200101261T2 (tr) Uzun süreli salınımlı ranolazin formülasyonları.
DE69635488D1 (de) Antivirale verbindung
DK342989D0 (da) Betaendelseshaemmende middel
WO1999012545A3 (en) Medicaments containing acyclovir
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
ES2047451B1 (es) Procedimiento para la preparacion de una composicion farmaceutica oral estable.
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
MY106605A (en) Compositions for the treatment of leishmaniasis